Biomedicine - investment
into the future
Secure potential in the growth market of dermatology now
Biomedicine is the window into the future of medicine. Biomedicine relies on the molecular and cell biological building blocks to identify and prevent diseases. Nanotechnology, biotechnology, as well as digital solutions open up innovative and tailored therapeutic options for new drugs or medical devices. These promising approaches offer great potential for investors looking for investments in a dynamic future market.
Ethical-ecological investment in global health
Global health and access to modern medical treatment is one of the greatest challenges facing our societies. Biomedicine is the answer on the way to individualised medicine - with therapeutic innovations for the general public. Biomedicine is therefore an ideal asset for investors who, in addition to the economic success of their investment, are looking for an ethical-ecological investment with sustainable impact.
Sustainable
Financial investments
for maximum success
- bioXXmed AG is your competent partner for an investment in biomedicine. As a holding company and active portfolio manager, we finance the development of innovative products for the diagnosis, relief or cure of diseases in a broad range of medical conditions. The current focus of investment activities is in the field of dermatology. Our target companies have patented, application-oriented technologies or products with a long remaining patent life. Clinical target indications should show a high "medical need", i.e., unsatisfactory therapeutic standard.
Skin
as a mirror of life
Dermatology is an important growth area in biomedicine. Wound therapy, especially in diabetes, is of particular importance. More than 150 million people worldwide are affected by acute and chronic wounds every year. bioXXmed AG focuses on the advanced treatment of wounds and invests in innovative approaches of medical products and novel technologies in regenerative medicine.